Pinned Tweet
Right on the heels of our press release announcing a deal with Novo Nordisk, we're thrilled to see this NY Times coverage of the partnership and Variant Bio's ethics-first approach to drug discovery: nytimes.com/2025/01/07/healt…
Variant Bio retweeted
Lux family co @VariantBio
we created + funded this company to find outlier people in outlier parts of the world with outlier traits...
to develop new drugs for all of the rest of us.
Out today on the cover of @ScienceMagazine: work led by @KeoluFox (UCSD) and Alexander Ioannidis (Stanford) with @VariantBio. Polynesians experienced founder effects 10x stronger than Finland’s, with big implications for drug discovery and clinical care: science.org/doi/10.1126/scie…
Out today on the cover of @ScienceMagazine: work led by @KeoluFox (UCSD) and Alexander Ioannidis (Stanford) with @VariantBio. Polynesians experienced founder effects 10x stronger than Finland’s, with big implications for drug discovery and clinical care: science.org/doi/10.1126/scie…
Dr. Sarah LeBaron von Baeyer from Variant Bio presenting with our brilliant partner Dr. June Fabian from the University of the Witwatersrand on how we have together implemented the community-driven distribution of financial benefits for genomics research projects in South Africa.
Variant Bio leverages AI-powered Inference platform in an expanded collaboration with @Boehringer: medium.com/variantbio/expand…
Thrilled to announce our latest drug development collaboration! We are now expanding our existing partnership with @Boehringer into cardiovascular disease for a total potential deal value exceeding $250 mm: prnewswire.com/news-releases…
Check out this upcoming webinar by our very own @OliviaG_PhD! Register here 👉 zoom.us/webinar/register/WN_…
Variant Bio’s Senior Director of Ethics & Engagement discusses lessons learned from educational and health initiatives in Rwanda: medium.com/variantbio/taking…
We recently wrapped up recruitment for a genomic research study in Tahiti in partnership with Novo Nordisk and GHICL: medium.com/variantbio/conclu…
We are thrilled to announce our latest paper published with the Faroe Genome (FarGen) project and the University of Copenhagen: medium.com/variantbio/paper-…
Variant Bio retweeted
Join our webinar with Dr. Olivia Gray (@VariantBio) tomorrow!
Learn how multiomics revealed mechanisms affecting creatinine-based eGFR estimates in African ancestry populations.
📅 27 May
🕒 11 am EDT | 5 pm CEST
🔗bit.ly/4nIaF1Q
Can genetics bias kidney disease biomarkers?
In our next webinar, Dr. Olivia Gray (@VariantBio) will show how multiomics revealed mechanisms affecting creatinine-based eGFR estimates in African ancestry populations.
📅 27 May
🕑 11 am EDT | 5 pm CEST
🔗 bit.ly/4nIaF1Q
Variant Bio retweeted
Can genetics bias kidney disease biomarkers?
In our next webinar, Dr. Olivia Gray (@VariantBio) will show how multiomics revealed mechanisms affecting creatinine-based eGFR estimates in African ancestry populations.
📅 27 May
🕑 11 am EDT | 5 pm CEST
🔗 bit.ly/4nIaF1Q
Variant Bio recently launched a new study focused on diabetes in Bangladesh in partnership with Novo Nordisk and icddr,b: medium.com/variantbio/empowe…
In honor of International Nurses Day -- celebrated on the anniversary of Florence Nightingale's birth -- the team @VariantBio owes a huge THANK YOU to nurses around the world (including in Tahiti, pictured here) who make our research studies possible. Cheers to nurses everywhere!
Dr. Moira Gunn from @biotechnation interviewed @AndrewFarnum and Dr. Sarah LeBaron von Baeyer from @VariantBio for NPR this week on how AI, ethics, and diverse data can help us develop better drugs and diagnostics: medium.com/variantbio/varian…
Variant Bio retweeted
Alpha in biotech comes from looking where no one else is. At @VariantBio, we’ve built a proprietary engine to uncover human genetic evidence that the rest of the industry is missing. I had a great deep dive into the ethics and science of our approach on @biotechnation today.
Variant Bio retweeted
Thank you for hosting a great conversation on our work @VariantBio, Dr. Moira Gunn! @biotechnation biotechnation.com/episodes/t…
“In the era of precision medicine, [a]dding more data from the global north may offer only incremental insight, whereas African data has the potential for genuinely novel discovery. It is a meaningful step toward inclusion and equity”: wits.ac.za/news/latest-news/…
In honor of National Doctors' Day today, we would like to thank all the doctors we have worked with in partner communities around the world, as well as the doctors who are committed to helping patients with the new medicines we are developing @VariantBio.
Coverage of Variant Bio's collaboration with Prof. Lyn Griffiths and the QUT Centre for Genomics and Personalised Health on the genetic and multi-omic landscape of metabolic conditions in Pasifika communities in Australia: miragenews.com/2-1m-queensla…
Variant Bio recently launched a study with Novo Nordisk, this time in partnership with the University of Otago and Pukapuka Community Group: medium.com/variantbio/kickin…












